Multiple Sclerosis Journal has selected the recent Tisch MS publication "Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis," co-authored by Violaine Harris, PhD, and Saud Sadiq, MD, among others, as its cover article for October 2013. This important biomarker discovery is based on spinal fluid measurement of Fetuin-A levels obtained over the course of several years of clinical and pathological studies of MS patients as well as experimental models of the disease. Our findings are likely to change the process for making treatment decisions in MS patients.
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.